This inventor holds 1 USPTO granted patent and 3 published patent applications and 3 EPO patents. Top assignee: Metanomics Health Gmbh. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Bodo Schniewind: Innovator in Pancreatic Cancer Diagnostics
Introduction
Bodo Schniewind is a notable inventor based in Kiel, Germany. He has made significant contributions to the field of diagnostic methods, particularly in the diagnosis of pancreatic cancer. His innovative approach focuses on utilizing a metabolite panel to enhance diagnostic accuracy.
Latest Patents
Bodo Schniewind holds a patent titled "Means and methods for diagnosing pancreatic cancer in a subject based on a metabolite panel." This invention relates to methods for diagnosing pancreatic cancer and differentiating it from pancreatitis. It also includes tools for implementing these diagnostic methods, such as specialized diagnostic devices.
Career Highlights
Throughout his career, Schniewind has worked with prominent organizations, including Metanomics Health GmbH and Universitätsklinikum Schleswig-Holstein. His work has been instrumental in advancing diagnostic techniques in the medical field.
Collaborations
Schniewind has collaborated with notable colleagues, including Beate Kamlage and Regina Reszka. These partnerships have contributed to the development and refinement of his innovative diagnostic methods.
Conclusion
Bodo Schniewind's work in pancreatic cancer diagnostics exemplifies the impact of innovation in medicine. His patent and collaborations highlight the importance of advancing diagnostic techniques for better patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile